Neumora Therapeutics (NMRA) Treasury Shares (2022 - 2023)

Neumora Therapeutics' Treasury Shares history runs 5 years deep, the most recent figure standing at $435000.0 for Q1 2026.

• In Q1 2026, Treasury Shares rose 291.89% year-over-year to $435000.0; the TTM figure through Mar 2026 stood at $435000.0 (up 291.89% YoY), while the FY2025 annual figure was $662000.0, up 78.44% from the prior year.
• Treasury Shares for Q1 2026 stood at $435000.0, down from $662000.0 in the prior quarter.
• The five-year high for Treasury Shares was $104.4 million in Q4 2022, with the low at $111000.0 in Q1 2025.
• The 5-year median for Treasury Shares is $1.5 million (2024), against an average of $28.3 million.
• The sharpest annual moves came in 2023 and 2026: Treasury Shares plunged 99.2% in 2023, then soared 291.89% in 2026.
• Neumora Therapeutics' Treasury Shares stood at $104.4 million in 2022, then slumped by 99.2% to $840000.0 in 2023, then sank by 55.83% to $371000.0 in 2024, then jumped by 78.44% to $662000.0 in 2025, then sank by 34.29% to $435000.0 in 2026.
• Business Quant data shows NMRA's Treasury Shares at $435000.0 in Q1 2026, $662000.0 in Q4 2025, and $662000.0 in Q3 2025.